Royce & Associates LP Perkinelmer Inc Transaction History

Royce & Associates LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	N/A	27,884 Added 97.91%	56,363 $6.82 Million
Q4 2023 Feb 12, 2024	BUY	N/A	28,479 New	28,479 $3.45 Million
Q1 2019 May 09, 2019	SELL	$72.79 - $97.5 $733,286 - $982,215	-10,074 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$71.87 - $97.02 $713,381 - $963,020	-9,926 Reduced 49.63%	10,074 $791,000
Q3 2018 Nov 13, 2018	BUY	$72.59 - $97.27 $725,900 - $972,700	10,000 Added 100.0%	20,000 $1.95 Million
Q2 2018 Aug 09, 2018	BUY	$72.1 - $79.39 $721,000 - $793,900	10,000 New	10,000 $732,000

571

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.